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Abstract  
Ursolic acid (UA) and oleanolic acid (OA) are triterpenes that are found in a large number of medicinal plants, one of which is the species Bouvardia 
ternifolia. These compounds have been shown to have around 120 types of biological activity, especially the hepatoprotective, anti-inflammatory and 
antimycobacterial effects. Despite having a high therapeutic potential, not much information concerning their toxicity is available. This article describes the 
results of acute and subacute (28 days) toxicity evaluations in Balb/c mice (both sexes) treated with the mixture of UA/OA obtained from B. ternifolia at 
doses of 6.5 and 13 mg/kg. The LD50 was >300 mg/kg. During the subacute administration, there was no death of animals and no changes were observed in 
the growth or weight of the different organs when compared to the control groups. Studies of blood chemistry and blood count showed normal levels in all 
parameters evaluated. The histopathology of major organs showed no changes or abnormalities. The mixture UA/OA is indeed safe when administered 
subcutaneously as a single dose of 300 mg/kg or in repeated doses of 13 mg/kg during 28 days. 
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Resumen 
Los ácidos ursólico (UA) y oleanólico (OA) son triterpenos que se encuentran distribuidos en un gran número de plantas medicinales, una de ellas es la 
especie Bouvardia ternifolia. Estos compuestos han mostrado alrededor de 120 actividades biológicas, destacando los efectos hepatoprotector, 
antiinflamatorio y antimicobacteriano. A pesar de ser compuestos con un alto potencial terapéutico, no se han documentado muchos datos acerca de su 
toxicidad. En este artículo se describen los resultados de la evaluación de toxicidad aguda y subaguda (28 días) en ratones Balb/c de ambos sexos, tratados con 
la mezcla de AU/AO obtenida de B. ternifolia a dosis de 6.5 y 13 mg/kg.  La DL50 fue > 300 mg/kg. Durante la administración subaguda, no hubo muerte de 
animales, tampoco se observaron alteraciones en su crecimiento ni alteraciones en el peso de los diferentes órganos. Los estudios de biometría hemática y 
química sanguínea mostraron niveles normales en todos los parámetros evaluados. Los análisis histopatológicos de los principales órganos no presentaron 
cambios o anormalidades. La mezcla UA/OA es practicamente inocua cuando se administra subcutaneamente en dosis única de 300 mg/kg y 13 mg/kg en 
dosis repetida (28 días). 
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List of abbreviations: UA - Ursolic Acid; OA - Oleanolic Acid; 
NAPRALERT - Natural Products Alert; COX - Cyclooxygenase; 
MIC – Minimum Inhibitory Concentration; MABA - Microplate 
Alamar Blue Assay; TB - Tuberculosis; MDR - Multidrug-
resistant; XDR - Extensively Drug-Resistant; LC50 – Lethal 
Concentration 50; LD50 – Lethal Dose 50; 
1H-NMR - Nuclear 
Magnetic Resonance; TMS - Tetramethylsilane; EI-MS - Electron 
Impact-Mass Spectra; CC - Column Chromatography; TLC - Thin 
Layer Chromatography; HEX - n-Hexane; CH3CN – acetonitrile; 
CHCl3 – Chloroform; MeOH – Methanol; HPLC - High 
Performance Liquid Chromatography; OECD - Organization for 
Economic Cooperation and Development; GHS - Globally 
Harmonised Classification System; SEM - Standard Error of 
Mean; ANOVA - Analysis of Variance; WBC - White Blood 
Cells;  RBC - Red Blood Cells; HGB – Hemoglobin; HCT - 
Hematocrit, MCV - Mean Corpuscular Volume; MCHC - Mean 
Corpuscular Hemoglobin Concentration; SGOT - Serum Glutamic 
Oxaloacetic Transaminase; SGPT - Serum Glutamic Pyruvic 
Transaminase. 
 
INTRODUCTION 
Triterpenes, such as ursolic acid (UA) and 
oleanolic acid (OA), are secondary metabolites present 
in different plant species (Ovesná et al., 2004; Somova 
et al., 2003). To date, around 120 types of biological 
activity have been discovered for these compounds, 
according to data recorded in the Natural Products 
Alert Database (NAPRALERT, 2011), including anti-
HIV, antiplasmodial, cytotoxic, antibacterial, anti-
inflammatory (lipoxygenase and Cyclooxygenase 
[COX] inhibitor), antitumoral, hepatoprotective (in 
vivo), and antidiabetogenic activity (Jaki et al., 2008; 
Liu, 1995, 2005).  
Previous investigation has shown that UA and 
OA, obtained from different plant species, exhibit 
moderate to high in vitro antimycobacterial activity 
against Mycobacterium tuberculosis H37Rv (Cantrell 
et al., 2001; Copp and Pearce, 2007; Gu et al., 2004; 
Okunade et al., 2004; Wächter et al,. 1999; 2001). 
Regarding this activity, a minimum inhibitory 
concentration (MIC) of 15 g/mL or 32 M has been 
reported for UA and 30 g/mL or 64 M for OA when 
it was tested by the BACTEC 460 radiospirometric 
method, and 41.9 and 28.7 g/mL respectively, when 
evaluated by the Microplate Alamar Blue Assay 
(MABA) test (Cantrell et al., 2001; Gu et al., 2004; 
Wächter et al. 1999, 2001). Recently, it was reported 
that OA exerts a synergistic effect when was combined 
with isoniazid, (I) rifampicin (R) or ethambutol (first 
line antitubercular drugs) (Ge et al., 2010). Moreover, 
the antimycobacterial effect reportedly depends on the 
purity of each compound; for example, high-purity UA 
(98.6%) has an MIC value > 256 g/mL, while UA 
with 69.6% purity has an MIC = 65 g/mL (Jaki et al., 
2008). 
On the other hand, it is important to note that 
the search for compounds with antitubercular activity 
is urgent because of health problems in which 
tuberculosis (TB) is associated with the emergence of 
multidrug-resistant (MDR) and extensively drug-
resistant (XDR) TB strains, which are resistant to R 
and I, the principal (basic) drugs in the treatment of 
TB. It is known that first- and second-line anti-TB 
drugs produce severe toxic effects from prolonged use, 
causing low adherence to or the abandonment of 
treatment. For example, I and R cause hepatotoxicity 
(Yogeeta et al., 2007), because they generate the 
production of oxygen-free radicals, initiate lipid 
peroxidation and produce oxidative stress. Other types 
of damage caused by TB drugs include peripheral 
neuropathy, fever, convulsions, hyperuricemia, 
photosensitivity, renal toxicity and renal failure.  
Despite the diverse biological activity 
described for UA and OA, to date no data have been 
documented on acute and subacute toxicity for these 
compounds. The only data in this regard are the 
median lethal concentrations (LC50) for UA and OA, 
tested in Artemia salina (Brine shrimp test), with 
values of 0.10 and 0.95 mg/mL, respectively (Somova 
et al., 2003).  
In this paper, we describe the LD50 and the 
subacute toxicity caused by a 28-day administration in 
healthy Balb/c mice with the mixture of UA/OA 
obtained from Bouvardia ternifolia. The effects of this 
mixture were determined by measurement of body and 
organ weight, as well as hematological and 
biochemical parameters. Histological analyses of the 
data were carried out. 
 
MATERIALS AND METHODS 
General experimental procedures 
The chemical characterization of the isolated 
triterpenoids was determined by nuclear magnetic 
resonance (
1
H-NMR, Bruker-Avance F, 300 MHz) 
using Tetramethylsilane (TMS) as an internal 
standard in CDCl3. Electron impact-mass spectra (EI-
MS) were obtained on a Jeol AX-505 HA mass 
spectrometer at 70 eV. Melting points (m.p.) were 
determined on a Fisher-Johns apparatus and are 
uncorrected. All spectroscopic and spectrometric 
data of each compound were compared with those 
previously reported in the literature.  
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Open-column chromatography (CC) was 
carried out utilizing silica gel 60 GF254  (70-230 
mesh, Merck) as the stationary phase. Silica gel 60 
F254 recoated aluminum plates (0.2 mm, Merck) were 
employed for analytical and preparative thin layer 
chromatography (TLC) analysis. n-Hexane (HEX), 
acetonitrile (CH3CN), chloroform (CHCl3) and 
methanol (MeOH) were obtained from Mallinckrodt 
and J.T. Baker. Spots were visualized by spraying 
with a 10% aqueous solution of H2SO4 followed by 
heating to 100ºC.   
High performance liquid chromatography 
(HPLC) was carried out with a Waters 600 system 
controller connected to a photodiode array detector 
996, which was programmed to take data from 220 to 
380 nm at 2.4-nm resolution. Control of equipment, 
data acquisition, processing, and handling of 
chromatographic information were carried out by the 
Millennium 32 software program (Waters). Analyses 
were undertaken on a Symmetry column (3.9 × 150 
mm, 5-µm particle sizes, Waters). The mobile phase 
comprised an isocratic CH3CN:MeOH (80:20) system 
(HPLC grade, J.T. Baker). The flow rate was 
maintained constant at 1.8 mL/min for 15 min. 
Samples were solubilized in MeOH at 1 mg/mL, and 
a volume of 100 µL was injected. 
 
Plant material 
B. ternifolia was collected in Miahuatlán, Oaxaca 
State, Mexico, in November of 2008. The species was 
botanically identified by Abigail Aguilar, M.Sc., and 
a voucher specimen was deposited at the Instituto 
Mexicano del Seguro Social (Mexico, IMSSM) 
Herbarium. 
 
Extraction and isolation of mixture of UA/OA 
Powdered, air-dried aerial particles were extracted 
with MeOH. The crude extract was obtained by 
maceration o f  plant material. After filtration, the 
extract was concentrated under low pressure to 
dryness at 40º C. B. ternifolia (0.7 kg) was macerated 
three times with 18, 12, and 8 L of MeOH, 
respectively. 
The MeOH extract of B. ternifolia was 
fractionated on CC, using HEX, CHCl3 and MeOH, 
as well as a mixture of these solvents with an 
increasing degree of polarity. The primary fraction 
eluted with CHCl3:MeOH (80:20) was fractionated by 
CC under the same conditions. Thirteen secondary 
fractions were grouped on the basis of TLC 
patterns. Afterward, the UA/OA mixture was purified 
from secondary fractions rich in this mixture. These 
triterpenoids were detected utilizing TLC and were 
compared with the commercial references (Sigma). 
UA/OA-rich primary or secondary fractions 
were successively extracted with CH3CN (three times, 
20 mL/g) and CHCl3 (three times, 10 mL/g). In each 
case, the supernatant was filtered through a 0.45 µm 
GH Polypro 47-mm filter (Pall) into millipore 
equipment. The solid residuum was dissolved in 
MeOH (20 mL/g) and filtered in the same millipore 
equipment. The MeOH solution was then treated with 
activated charcoal (Sigma, 5 mg/mL) in an Erlenmeyer 
flask and shaken for 10 min. Subsequently, this 
solution was filtered with the millipore equipment and 
concentrated by evaporation under reduced pressure to 
dryness at 40° C. 
 
Animals 
The experiment was performed on male and female 
Balb/c mice (body weight, 19-23 g) according to 
Organization for Economic Cooperation and 
Development (OECD) Test Guidelines (OECD, 
2007). All experiments were performed following the 
Mexican Official Norm for Animal Care Handing 
(NOM-062-ZOO-1999). The mice were housed in 
standard environmental conditions and were allowed 
free access to food and water, with 12-h light/dark 
photoperiods. The compounds were dissolved in 
extra virgin olive oil (Sigma). The concentrations 
were adjusted to subcutaneous (s.c.) administration at 
0.1 mL/mouse. 
 
Acute toxicity (median lethal dose–LD50) 
According to OECD TC423, a group of 3 mice of 
both sexes was administered s.c. at single doses of 
300 mg/kg. The general behavior of the mice was 
observed after administration at the 1st, 2nd, 4th, 
and 6th h, and once daily for 14 days. During this 
14-day period, the animals were also observed to 
detect any signs of toxicity o r  death. At the end of 
the experiments, the animals were sacrificed in a 
CO2 chamber. Subsequently, their organs (lung, 
kidney, heart, spleen and liver) were extracted and 
gross pathological observations were performed. The 
LD50 value was determined according to the Globally 
Harmonized Classification System (GHS) and to the 
flow chart for this study (OECD, 2007). 
 
Subacute toxicity (repeated-dose, 28-day toxicity) 
According to OECD TG407 (OECD, 2007), mice 
were randomly divided into four groups of 5 animals 
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per sex. Group I was the control, group II was the 
vehicle control, and groups III and IV were s.c. 
treated with the mixture of UA/OA at 6.5 and 13 
mg/kg for 28 days. These doses corresponded to 5 and 
10 times the MIC of the mixture against M. 
tuberculosis H37Rv in vitro. Toxic manifestations 
such as signs mortality and body weight changes 
were monitored daily. At the end of treatment (day 
28), the animals were fasted overnight, with water 
provided ad libitum. Subsequently, the mice were 
anesthetized with xylazine and ketamine. Heparinized 
blood samples were drawn to determine complete 
blood count and red blood cell count. Serum from 
non-heparinized blood was carefully collected for 
blood chemistry and enzyme analysis.  
 
Histological analyses   
All animals were euthanized and their main vital 
organs were removed and macroscopically analyzed. 
After macroscopic analysis, representative fragments 
of spleen, heart, stomach, intestine, skin, lung, 
kidney and liver were subsequently fixed in a 10% 
solution of formalin and enclosed in paraffin. Paraffin 
blocks were prepared after completing tissue 
processing in different grades of alcohol and xylenes. 
Sections (5-μm) were prepared from blocks 
employing microtome and stained with hematoxylin 
and eosin (H&E). Images were taken using a camera 
connected to the microscope to examine cellular 
damage. 
 
Statistical analysis  
Results were expressed as mean ± Standard error 
(SEM). Statistical significance was determined by 
one-way Analysis of variance (ANOVA) and post-hoc 
least-significant-difference (Bonferroni post-test).  
 
RESULTS AND DISCUSSION 
Previous research has indicated that B. ternifolia 
biosynthesizes UA and OA (Jiménez-Ferrer et al., 
2005; Pérez et al., 1998). Thus, it was decided to 
perform a chemical study of the MeOH extract of this 
plant. The crude extract (82 g) was obtained by the 
maceration process from the aerial parts of B. 
ternifolia (700 g of dry material), with an efficiency of 
11.7%. After successive chromatographic procedures, 
3 g of the mixture of UA (1) and OA (2) (rate, 2:1) 
were obtained. This mixture was characterized 
structurally by 
1
H-NMR and EI-MS data and 
compared with the commercial references (Sigma). 
These UA/OA mixtures were obtained as white 
powder with an m.p. of 268-270.8°C; this m.p. is 
similar to those of commercial references (e.g., 
Sigma, m.p., 276.2-279.5°C). HPLC analysis showed 
that natural compounds have similar retention times 
(RT) to commercial references: the chromatogram had 
two peaks, with an RT of 7.21 and 7.67 by B. 
ternifolia, and of 7.22 and 7.65 from commercial 
references (Figure 1).  
The LD50 of the UA/OA mixture obtained 
from B. ternifolia in both sexes of Balb/c mice was 
>300 mg/kg according to the TG423 method. At this 
dose, no deaths or hazardous signs of toxicity were 
recorded in these animals during the 14 day period of 
observation after acute treatment by the s.c. route. 
Evaluations at higher doses were not performed since 
the biologically active concentration employed for 
each of these compounds is much lower. For example, 
the ID50 for UA is 56 µg/cm
2
 and for OA is 132 
µg/cm
2
, in both cases as an anti-inflammatory agent. 
For both compounds, the MIC value is 50 g/mL as 
an antimycobacterial agent, and is 200 mol/kg as a 
hepatoprotective agent (Cantrell et al., 2001; Gu et 
al., 2004; Ismaili et al., 2004; Liu et al., 1994; 
Wachter et al. 1999; 2001). A previous report 
described that the LC50 in A. salina is 0.10 and 0.95 
mg/mL, respectively, for UA and OA. Considering 
that Logarto-Parra et al. (2001) described the 
existence of a direct correlation between the LC50 
determined in A. salina and the same value 
determined in mice, we would expect an LD50 >5000 
mg/kg. 
Regarding the subacute analysis, no signs of 
toxicity (such as piloerection and alteration in 
locomotor activity) or mortality were observed in the 
treated groups compared to the control groups for 
either sex. Body weights are depicted in Table 1 and 
no significant variations in this parameter were 
detected during the treatment period. The organ 
weights showed no significant difference between the 
control and the vehicle group (Table 2). The internal 
organs did not exhibit any gross morphological 
lesions. The results obtained indicate that the UA/OA 
mixture does not affect the growth of mice during the 
treatment period nor does it affect the weight of their 
principal organs. 
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Figure 1 
.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UA (1)                                                                              OA (2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Upper: representative high performance liquid chromatography (HPLC) chromatogram of the mixture of ursolic 
acid/oleanolic acid (UA/OA) 1:1 (Sigma); RT = 7.22 and 7.65. Lower: representative HPLC chromatogram of the 
mixture of ursolic acid/oleanolic acid (UA/OA) 2:1 (Bouvardia ternifolia); RT = 7.21 and 7.67. 
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Table 1 
Body weights of mice with the regimen of subacute toxicity of UA/OA 
  Body weight (g) 
  Day 0  Day 14  Day 28  Weight gain on day 14 
Females             
Control  20.78 ± 0.57  21.43 ± 0.71  21.93 ± 0.70  1.30 ± 0.46 
Vehicle  21.02 ± 0.43  22.06 ± 0.16  22.92 ± 0.14  2.18 ± 0.13 
UA-OAa  20.67 ± 0.25  21.80 ± 0.55  22.62 ± 0.69  1.95 ± 0.55 
UA-OAb  21.12 ± 0.51  22.11 ± 0.34  22.61 ±  0.28  1.85 ± 0.31 
             
Males             
Control  20.73 ± 0.65  22.30 ± 0.79  24.08 ± 1.45  2.35 ± 0.80 
Vehicle  20.23 ± 0.64  23.25 ± 0.38  25.08 ± 0.65  3.02 ± 0.52 
UA-OAa  20.23 ± 0.64  23.25 ± 0.38  25.08 ± 0.65  3.02 ± 0.52 
UA-OAb  20.18 ± 0.30  22.57 ± 0.53  24.10 ± 0.91  2.39 ± 0.44 
Values are expressed as the mean ± standard error (SEM), n = 5; UA = ursolic acid; OA = oleanolic acid. 
 a
A group 
was given UA/OA 6.5 mg/kg; 
b
A group was given UA/OA 13 mg/kg. 
 
 
Table 2 
Organ weights of mice with the regimen of subacute toxicity of UA/OA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as the mean ± standard error (SEM), n = 5; UA = ursolic acid; OA = oleanolic acid;. 
a
A group was given UA/OA 6.5 mg/kg; 
b
A group was given UA/OA 13 mg/kg. 
 
 
 
 
Organ weights (g) 
 
 
Control 
 
Vehicle 
 
UA/OAa 
 
UA/OAb 
Females  
 
  
 
  
 
  
 
  
Spleen 
 
0.45 ± 0.02 
     
0.54 ± 0.07 
 
0.54 ± 0.02 
 
0.53 ± 0.02 
Heart 
 
0.51 ± 0.03 
 
0.48 ± 0.09 
 
0.53 ± 0.08 
 
0.52 ± 0.02 
Liver 
 
4.24 ± 0.55 
 
4.31 ± 0.12 
 
4.34 ± 0.30 
 
4.23 ± 0.09 
Kidney 
 
1.14 ± 0.02 
 
1.13 ± 0.05 
 
1.12 ± 0.08 
 
1.14 ± 0.05 
Lung 
 
0.71 ± 0.02 
 
0.66 ± 0.09 
 
0.75 ± 0.02 
 
0.71 ± 0.02 
Brain 
 
1.77 ± 0.03 
 
1.81 ± 0.10 
 
1.80 ± 0.08 
 
1.79 ± 0.05 
 
 
  
 
  
 
  
 
  
Males 
 
  
 
  
 
  
 
  
  Spleen 
 
0.41 ± 0.00 
 
0.41 ± 0.04 
 
0.47 ± 0.03 
 
0.51 ± 0.06 
  Heart 
 
0.63 ± 0.03 
 
0.61 ± 0.06 
 
0.59 ± 0.09 
 
0.63 ± 0.03 
  Liver 
 
4.71 ± 0.61 
 
4.86 ± 0.36 
 
4.87 ± 0.08 
 
4.99 ± 0.16 
  Kidney 
 
1.43 ± 0.05 
 
1.40 ± 0.05 
 
1.44 ± 0.02 
 
1.40 ± 0.13 
  Lung 
 
0.72 ± 0.05 
 
0.72 ± 0.03 
 
0.60 ± 0.03 
 
0.75 ± 0.05 
  Brain 
 
1.53 ± 0.06 
 
1.50 ± 0.10 
 
1.51 ± 0.04 
 
1.48 ± 0.03 
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The status of bone marrow activity and 
intravascular effects was monitored by hematological 
examination and the results are reported in Tables 3 
and 4. Values of white blood cells (WBC), 
lymphocytes, neutrophils, eosinophils, monocytes, 
basophils, red blood cells (RBC), hemoglobin  
(HGB), hematocrit (HCT), mean corpuscular volume 
(MCV) and mean corpuscular hemoglobin 
concentration (MCHC) exhibited no variation. 
Consequently, the 28-day administration of the 
UA/OA mixture at doses of 6.5 and 13 mg/kg did 
not induce any alteration in hematological or 
biochemical parameters. 
 
Table 3 
Hematological values of mice with the regimen of subacute toxicity of UA/OA 
  Group 
  Control  Vehicle  UA/OAa  UA/OAb 
Females             
RBC × (106 /uL)  9.28 ± 0.31  9.64 ± 0.26  8.83 ± 0.73  8.76 ± 1.09 
HGB (g/dL)  14.80 ± 0.32  14.65 ± 1.24  16.03 ± 0.95  15.35 ± 2.06 
HCT (%)  45.20 ± 1.79  47.33 ± 1.85  42.53 ± 3.53  41.68 ± 4.85 
MCV (fL)  48.70 ± 0.75  49.08 ± 0.64  48.38 ± 0.31  47.63 ± 0.36 
MCHC (g/dL)  32.73 ± 1.07  32.35 ± 1.53  36.10 ± 2.03  36.37 ± 2.16 
             
Males             
RBC × (106/uL)  9.65 ± 0.71  9.71 ± 0.67  9.15 ± 0.33  8.32 ± 0.96 
HGB (g/dL)  15.94 ± 0.67  16.04 ± 1.09  15.95 ± 0.35  14.75 ± 1.63 
HCT (%)  46.34 ± 2.61  46.74 ± 2.68  43.70 ± 1.13  39.80 ± 5.66 
MCV (fL)  48.08 ± 1.19  48.16 ± 0.86  47.80 ± 0.57  47.75 ± 1.34 
MCHC (g/dL)  34.40 ± 0.65  34.38 ± 1.54  36.60 ± 0.00  37.05 ± 1.20 
Values are expressed as the mean ± standard error (SEM), n = 5; RBC = Red blood cells; HGB = Hemoglobin; 
HCT = Hematocrit: MVC = Mean corpuscular volume; MCHC = Mean corpuscular hemoglobin concentration.
 a
A 
group was given UA/OA 6.5 mg/kg; 
 b
A group was given UA/OA 13 mg/kg. 
 
The results of blood chemistry parameters 
show that the values of total cholesterol, high-density 
lipoprotein (HDL) cholesterol and triglycerides do not 
present any significant difference between the 
treated and the control groups (Table 5), indicating 
that the UA/OA mixture did not cause any alteration 
in lipid metabolism. Similarly, the glucose levels 
present no significant difference between the two 
groups, which indicates that the mixture of 
compounds did not induce any alteration in 
carbohydrate metabolism (Table 5). There was no 
significant difference in levels of uric acid or 
creatinine, which indicates that the kidney function 
was not altered. Finally, there was no significant 
difference between the treated and control groups in 
relation to serum glutamic oxaloacetic transaminase 
(SGOT) or serum glutamic pyruvic transaminase 
(SGPT), indicating a lack of liver damage  by the 
treatment. 
To complete the subacute toxicity study, a 
histological examination was performed on the spleen, 
kidney, liver, heart, stomach, intestine, skin and lung 
from UA/OA-treated mice given the 13-mg/kg dose.   
Spleen slides of mice treated with the UA/OA 
mixture (Figure 2) demonstrated normal splenic 
architecture with normal lymphoid follicles and 
sinuses. These observations corroborate that the 
mixture of triterpenes did not produce alterations at 
the hematological level, because the RBC and WBC 
values were not affected. 
Kidney sections from animals treated with 
the triterpenoids mixture (Figure 2) showed a normal 
renal cortex with the normal appearance of 
glomerulus, tubules and renal papilla. Normal renal 
function was corroborated by the fact that the values 
of the uric acid and creatinine markers were not 
different between the study groups (Carvalho et al., 
2011).   Liver   sections   showed   normal   hepatic 
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architecture, hepatocytes, portal triad and central vein 
(Figure 2). These observations, combined with the 
serum levels of the transaminases evaluated, are 
employed to establish the lack of hepatocellular 
damage. These parameters are essential for 
recognizing liver damage induced by xenobiotics 
(Carvalho et al., 2011; Silva et al., 2011). 
 
Table 4 
Differential white blood cell count of mice with the regimen of subacute toxicity of UA/OA 
  Group 
  Control  Vehicle  UA/OAa  UA/OAb 
Females             
WBC (x× 103/uL)  3.53 ± 1.37  2.73 ± 0.89  5.08 ± 2.52  2.70 ± 1.59 
Lymphocytes (%)  84.50 ± 6.61  82.25 ± 12.76  87.50 ± 5.26  85.00 ± 5.16 
Neutrophils (%)  13.00 ± 5.03  16.75 ± 11.35  12.50 ± 5.26  13.25 ± 4.11 
Eosinophils (%)  0.50 ± 1.00  1.00 ± 2.00  0.50 ± 1.00  1.75 ± 2.06 
Monocytes (%)  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Basophils (%)  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
             
Males             
WBC (× 103/uL)  6.52 ± 1.47  5.80 ± 3.11  5.20 ± 1.98  2.80 ± 1.41 
Lymphocytes (%)  78.00 ± 2.58  81.10 ± 6.23  80.50 ± 4.95  78.50 ± 3.54 
Neutrophils (%)  20.50 ± 5.97  18.25 ± 2.36  17.00 ± 2.83  19.00 ± 9.90 
Eosinophils (%)  0.40 ± 0.89  0.80 ± 1.10  2.50 ± 0.71  2.20 ± 0.00 
Monocytes (%)  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Basophils (%)  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
Values are expressed as the mean ± standard error (SEM), n = 5; UA = Ursolic acid; OA = Oleanolic acid; WBC = 
White blood cells; 
 a
A group was given UA/OA 6.5 mg/kg; 
 b
A group was given UA/OA 13 mg/kg. 
 
Another organ that analyzed histologically 
was the heart. In this case, the slides showed normal 
endocardium and myocardium, as well as normal 
cardiac muscle architecture. Stomach and intestine 
sections showed normal mucosa, submucosa, and 
circular and longitudinal muscles layers. Skin 
sections exhibited normal epidermis, dermis, stratum 
corneum, hair follicles, and sebaceous glands, while 
the lung section demonstrated normal alveolar 
geometry and normal appearing alveolar septum 
(Figure 2).  
The histological analysis and the 
hematological and biochemical parameters are 
essential for an evaluation of the toxicological risk 
of substances with biological activity, because any 
changes in one of these parameters in animal 
studies can offer a high predictive value of possible 
damage in humans (Olson et al., 2000; Silva et al., 
2011). 
Medicinal plants and their derivatives have 
been employed as an alternative to allopathic medicine 
in many countries. Despite their widespread use, few 
scientific studies have been undertaken to ascertain the 
safety and efficacy of traditional remedies or pure 
compounds (Silva et al., 2011). In the case of TB, it is 
well known that two of the main antituberculosis drugs 
(R and I) cause hepatotoxicity (Saravanan and 
Pugalendi, 2006; Yogeeta et al., 2007), an effect that 
has an influence on treatment adherence. Therefore, an 
analysis of the toxic effect of the possible 
antituberculosis drugs should be carried out prior to 
clinical trials. In the case of the UA/OA mixture, it has 
been reported that both compounds exert a 
hepatoprotector effect on in vivo models after hepatic 
damage is induced with ethanol (Saravanan and 
Pugalendi, 2006), acetaminophen, CCl4, or D-
galactosamine, among others (Liu, 1993; 1995; Lezhi 
and Xintang, 1992). Likewise, it has been described 
that OA offers a hepatoprotector effect in patients with 
tuberculosis who are treated with antituberculosis 
drugs (Ge et al., 2010). Thus, in patients with TB this 
UA/OA mixture could offer a beneficial 
hepatoprotector and antimycobacterial effect.      
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Table 5 
Blood chemistry values of mice with the regimen of subacute toxicity of UA/OA 
  Group 
  Control  Vehicle  UA/OAa  UA/OAb 
Females             
Uric acid (mg/dL)  1.46 ± 0.11  1.44 ± 0.11  1.50 ± 0.12  1.47 ± 0.57 
Creatinine (mg/dL)  1.78 ± 0.09  1.86 ± 0.09  1.86 ± 0.14  1.81 ± 0.11 
Triglycerides (mmol/L)  0.98 ± 0.13  0.94 ± 0.13  0.96 ± 0.15  0.74 ± 0.05 
HDL cholesterol (mmol/L)  8.12 ± 0.23  8.24 ± 0.23  8.24 ± 0.38  8.28 ± 0.18 
Total cholesterol 
(mmol/L) 
 
10.60 ± 0.45 
 
10.80 ± 0.45 
 
10.80 ± 0.45 
 
10.40 ± 0.55 
SGPT (U/L)  32.60 ± 2.51  32.40 ± 2.51  32.60 ± 2.41  35.60 ± 1.52 
SGOT (U/L)  117.60 ± 10.13  120.20 ± 10.13  118.60 ± 9.29  124.20 ± 8.73 
Glucose (mg/dL)  373.60 ± 24.39  356.80 ± 24.39  374.67 ± 26.08  363.67 ± 18.01 
             
Males             
Uric acid (mg/dL)  1.18 ± 0.16  1.20 ± 0.19  1.26 ± 0.18  1.16 ± 0.21 
Creatinine (mg/dL)  1.75 ± 0.09  1.76 ± 0.05  1.71 ± 0.09  1.81 ± 0.05 
Triglycerides (mmol/L)  0.68 ± 0.08  0.68 ± 0.08  0.74 ± 0.09  0.72 ± 0.08 
HDL cholesterol (mmol/L)  10.82 ± 0.57  10.24 ± 0.47  10.48 ± 0.38  10.54 ± 0.32 
Total cholesterol 
(mmol/L) 
 
13.80 ± 0.84 
 
14.40 ± 1.52 
 
13.20 ± 0.84 
 
13.80 ± 0.45 
SGPT (U/L)  34.00 ± 3.00  36.20 ± 2.17  33.60 ± 2.19  34.40 ± 1.67 
SGOT (U/L)  128.80 ± 15.99  129.80 ± 11.01  123.00 ± 14.27  121.80 ± 18.51 
Glucose (mg/dL)  423.80 ± 12.58  421.80 ± 13.48  420.40 ± 12.66  425.40 ± 16.32 
Values are expressed as the mean ± standard error (SEM), n = 5; UA = Ursolic acid; OA = Oleanolic acid SGPT = Serum glutamic pyruvic 
transaminase; SGOT = Serum glutamic oxaloacetic transaminase.  aA group was given UA/OA 6.5 mg/kg; bA group was given UA/OA 13 
mg/kg. 
 
 
 
 
 
CONCLUSIONS 
The mixture of UA/OA is practically innocuous when 
its toxicity is evaluated by the s.c. route in acute (LD50 
> 300 mg/kg) and subacute (13 mg/kg repeated-dose, 
28-day toxicity) administration in Balb/c mice. 
Chronic toxicity, genotoxicity, and mutagenesis 
studies are required for further support concerning the 
safe use of these compounds. 
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Histologic specimens of tissues (spleen- x100, heart- x100, stomach- x100, intestine- x40, skin- x100, lung- x100, 
kidney- x40 and liver- x100) collected from mice euthanized on day 28, stained with H&E. UA = Ursolic acid; OA 
= Oleanolic acid. 
b
A group was given UA-OA 13 mg/kg. 
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